MASI vs. ITGR, TMDX, LIVN, CNMD, BRBR, JAZZ, ITCI, EXEL, INSP, and ACHC
Should you be buying Masimo stock or one of its competitors? The main competitors of Masimo include Integer (ITGR), TransMedics Group (TMDX), LivaNova (LIVN), CONMED (CNMD), BellRing Brands (BRBR), Jazz Pharmaceuticals (JAZZ), Intra-Cellular Therapies (ITCI), Exelixis (EXEL), Inspire Medical Systems (INSP), and Acadia Healthcare (ACHC). These companies are all part of the "medical" sector.
Integer (NYSE:ITGR) and Masimo (NASDAQ:MASI) are both mid-cap medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, earnings, media sentiment, analyst recommendations, profitability, risk, community ranking and dividends.
Integer has higher earnings, but lower revenue than Masimo. Integer is trading at a lower price-to-earnings ratio than Masimo, indicating that it is currently the more affordable of the two stocks.
Integer presently has a consensus price target of $120.50, indicating a potential upside of 8.30%. Masimo has a consensus price target of $137.43, indicating a potential upside of 0.31%. Given Masimo's stronger consensus rating and higher probable upside, equities research analysts plainly believe Integer is more favorable than Masimo.
In the previous week, Integer and Integer both had 12 articles in the media. Masimo's average media sentiment score of 0.73 beat Integer's score of 0.25 indicating that Integer is being referred to more favorably in the media.
Integer has a net margin of 6.01% compared to Integer's net margin of 3.98%. Integer's return on equity of 13.77% beat Masimo's return on equity.
99.3% of Integer shares are held by institutional investors. Comparatively, 86.0% of Masimo shares are held by institutional investors. 2.0% of Integer shares are held by company insiders. Comparatively, 9.7% of Masimo shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.
Masimo received 78 more outperform votes than Integer when rated by MarketBeat users. Likewise, 64.02% of users gave Masimo an outperform vote while only 63.39% of users gave Integer an outperform vote.
Integer has a beta of 1.12, meaning that its share price is 12% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.99, meaning that its share price is 1% less volatile than the S&P 500.
Summary
Integer beats Masimo on 9 of the 17 factors compared between the two stocks.
Get Masimo News Delivered to You Automatically
Sign up to receive the latest news and ratings for MASI and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MASI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
